Takeda Ventures

company

About

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

  • 1 - 10

Details

Industries
Finance,Financial Services,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2001
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
CVC

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. We are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance to entrepreneurs and early-stage companies driving concepts through clinical proof of concept. We also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Our goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Investments

Number of Investments
Number of Lead Investments
4
1
Takeda Ventures has made 4 investments. Their most recent investment was on Apr 19, 2021, when Adaptate Biotherapeutics raised £13M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A £13M Biotechnology
Series C $100M Biotechnology
Oct 3, 2019 Arcellx
Series B $85M Biopharma
Aug 8, 2018 Ambys Medicines
Series A $60M Biotechnology Yes